CD5 and lymphoma: We quantitated the cytotoxic activity in a 1:1 effector-to-target ratio on lymphoma cells (CD5+ CD7‒) from three different patients and found that all CAR constructs were highly effective to eliminate lymphoma cells compared to NK cells not expressing a CAR (Figure 3E).